At a glance
ClinicalIndex Comparison Record- ✓SCID-confirmed diagnosis of schizophrenia or schizoaffective disorder
- ✓Partially remitted: symptomatic despite antipsychotic benefit, due to inadequate efficacy, inability to tolerate therapeutic dose, or significant side effects
- ✓At least 2 months of antipsychotic treatment prior to enrollment
- ✓Regular outpatient mental health services: at least one visit every 3 months for the past 6 months
- ✕Severe current symptoms or side effects necessitating urgent medication change
- ✕Currently taking 3 or more antipsychotic medications for daily use (PRN and mood stabilizers allowed)
- ✕Current or prior treatment with clozapine
- ✕Psychiatric hospitalization within the past 3 months
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effectiveness of Switching Antipsychotic Medications
In Brief
A Phase 4 clinical trial evaluating Risperidone, Olanzapine, and 3 other interventions for Schizophrenia. Completed, enrolled 219 participants.
Detailed Summary
This study will evaluate the effectiveness of switching medications in decreasing schizophrenia symptoms in individuals who are currently taking an antipsychotic medication for the treatment of schizophrenia.
Study Details
Timeline
Interventions
As prescribed by routine prescriber (not dictated by study protocol)
As prescribed by routine prescriber (not dictated by study protocol)
As prescribed by routine prescriber (not dictated by study protocol)
As prescribed by routine prescriber (not dictated by study protocol)
As prescribed by routine prescriber (not dictated by study protocol)